---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033876"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:40:57.146279+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharma receives Nasdaq non-compliance notice for late Q2 10-Q filing

## Summary
- Nasdaq notified on Aug 21, 2024 of non-compliance with Listing Rule 5250(c)(1) due to delayed Q2 10-Q.
- Delay caused by re-audit of 2022 financials after SEC sanctions on former auditor B.F. Borgers CPA.
- Company expects to file amended 10-K/A for 2023 and amended Q1 10-Q in days, then Q2 10-Q to regain compliance.
- If more time needed, can submit compliance plan within 60 days for up to 180-day extension.
- Nasdaq notice has no immediate effect on listing of SHPH common stock on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-24-033876
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315224033876/0001493152-24-033876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315224033876/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033876
- JSON: https://secwatch.observer/filing/0001493152-24-033876.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033876.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.